source
- Amgen seeks FDA review of Tavneos to determine continued market availabilityAmgen has formally asked the U.S. Food and Drug Administration to re-examine the data supporting its drug Tavneos (avacopan). Tavneos is indicated for a rare form of vasculitis and the request sig…
- Eli Lilly backs health-tech startup Abridge to expand clinical trial recruitmentEli Lilly’s venture arm has made an investment in Abridge, a health‑technology company that is moving into the clinical trial recruitment space. The funding is intended to help Abridge broaden its…